An Enhancer Within Abcb11 Regulates G6pc2 in C57BL/6 Mouse Pancreatic Islets

Overview

Journal Diabetes

Specialty Endocrinology

Date 2023 Aug 8

PMID 37552875

Authors

Mark P Keller

Emily M Hawes

Kathryn L Schueler

Donnie S Stapleton

Kelly A Mitok

Shane P Simonett

James K Oeser

Leesa L Sampson

Alan D Attie

Mark A Magnuson

Richard M OBrien

Affiliations

Soon will be listed here.

Abstract

Article Highlights:

Citing Articles

Multiple promoter and enhancer differences likely contribute to augmented G6PC2 expression in human versus mouse pancreatic islet alpha cells.

Martin C, Oeser J, Wangmo T, Flemming B, Attie A, Keller M J Mol Endocrinol. 2024; 73(3).

PMID: 39121091 PMC: 11439184. DOI: 10.1530/JME-24-0051.

References

OBrien R . Moving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose. Curr Diab Rep. 2013; 13(6):768-77. PMC: 4041587. DOI: 10.1007/s11892-013-0422-8. View

Chen W, Erdos M, Jackson A, Saxena R, Sanna S, Silver K . Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest. 2008; 118(7):2620-8. PMC: 2398737. DOI: 10.1172/JCI34566. View

Miguel-Escalada I, Bonas-Guarch S, Cebola I, Ponsa-Cobas J, Mendieta-Esteban J, Atla G . Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nat Genet. 2019; 51(7):1137-1148. PMC: 6640048. DOI: 10.1038/s41588-019-0457-0. View

Mitok K, Freiberger E, Schueler K, Rabaglia M, Stapleton D, Kwiecien N . Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion. J Biol Chem. 2018; 293(16):5860-5877. PMC: 5912463. DOI: 10.1074/jbc.RA117.001102. View

Pasquali L, Gaulton K, Rodriguez-Segui S, Mularoni L, Miguel-Escalada I, Akerman I . Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat Genet. 2014; 46(2):136-143. PMC: 3935450. DOI: 10.1038/ng.2870. View

Greenwald W, Chiou J, Yan J, Qiu Y, Dai N, Wang A . Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk. Nat Commun. 2019; 10(1):2078. PMC: 6505525. DOI: 10.1038/s41467-019-09975-4. View

Blackwood E, Kadonaga J . Going the distance: a current view of enhancer action. Science. 1998; 281(5373):60-3. DOI: 10.1126/science.281.5373.60. View

Wang Y, Martin C, Oeser J, Sarkar S, McGuinness O, Hutton J . Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Diabetologia. 2007; 50(4):774-8. DOI: 10.1007/s00125-006-0564-1. View

Frigeri C, Martin C, Svitek C, Oeser J, Hutton J, Gannon M . The proximal islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen promoter is sufficient to initiate but not maintain transgene expression in mouse islets in vivo. Diabetes. 2004; 53(7):1754-64. DOI: 10.2337/diabetes.53.7.1754. View

10.

Pound L, Oeser J, OBrien T, Wang Y, Faulman C, Dadi P . G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes. 2013; 62(5):1547-56. PMC: 3636628. DOI: 10.2337/db12-1067. View

11.

Wang Y, Flemming B, Martin C, Allen S, Walters J, Oeser J . Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo. Diabetes. 2007; 57(1):133-41. DOI: 10.2337/db07-0092. View

12.

Martin C, Svitek C, Oeser J, Henderson E, Stein R, OBrien R . Upstream stimulatory factor (USF) and neurogenic differentiation/beta-cell E box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression. Biochem J. 2003; 371(Pt 3):675-86. PMC: 1223330. DOI: 10.1042/BJ20021585. View

13.

Bouatia-Naji N, Bonnefond A, Baerenwald D, Marchand M, Bugliani M, Marchetti P . Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels. Diabetes. 2010; 59(10):2662-71. PMC: 3279535. DOI: 10.2337/db10-0389. View

14.

Martin C, Oeser J, OBrien R . Differential regulation of islet-specific glucose-6-phosphatase catalytic subunit-related protein gene transcription by Pax-6 and Pdx-1. J Biol Chem. 2004; 279(33):34277-89. DOI: 10.1074/jbc.M404830200. View

15.

Dong C, Simonett S, Shin S, Stapleton D, Schueler K, Churchill G . INFIMA leverages multi-omics model organism data to identify effector genes of human GWAS variants. Genome Biol. 2021; 22(1):241. PMC: 8381555. DOI: 10.1186/s13059-021-02450-8. View

16.

Hutton J, OBrien R . Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem. 2009; 284(43):29241-5. PMC: 2785553. DOI: 10.1074/jbc.R109.025544. View

17.

Panigrahi A, OMalley B . Mechanisms of enhancer action: the known and the unknown. Genome Biol. 2021; 22(1):108. PMC: 8051032. DOI: 10.1186/s13059-021-02322-1. View

18.

Bosma K, Rahim M, Singh K, Goleva S, Wall M, Xia J . Pancreatic islet beta cell-specific deletion of G6pc2 reduces fasting blood glucose. J Mol Endocrinol. 2020; 64(4):235-248. PMC: 7331801. DOI: 10.1530/JME-20-0031. View

19.

Overway E, Bosma K, Claxton D, Oeser J, Singh K, Breidenbach L . Nonsynonymous single-nucleotide polymorphisms in the G6PC2 gene affect protein expression, enzyme activity, and fasting blood glucose. J Biol Chem. 2021; 298(2):101534. PMC: 8800118. DOI: 10.1016/j.jbc.2021.101534. View

20.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View